Activated clotting time during cardiopulmonary bypass: is repetition necessary during open heart surgery?
D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D001780:Blood Coagulation Tests; D002315:Cardiopulmonary Bypass; D015331:Cohort Studies; D001026:Coronary Artery Bypass / Q000009:adverse effects / Q000379:methods*; D003327:Coronary Disease / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000601:surgery*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006493:Heparin / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D016343:Monitoring, Intraoperative / Q000379:methods*; D011300:Preoperative Care; D011859:Radiography; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D013997:Time Factors; D019564:Unnecessary Procedures; D014914:Whole Blood Coagulation Time
D000925:Anticoagulants; D006493:Heparin